Inge Pareyn

1.3k total citations
43 papers, 950 citations indexed

About

Inge Pareyn is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Inge Pareyn has authored 43 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 27 papers in Immunology and 11 papers in Genetics. Recurrent topics in Inge Pareyn's work include Platelet Disorders and Treatments (26 papers), Complement system in diseases (26 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Inge Pareyn is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Complement system in diseases (26 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). Inge Pareyn collaborates with scholars based in Belgium, United States and France. Inge Pareyn's co-authors include Karen Vanhoorelbeke, Hans Deckmyn, Nele Vandeputte, Simon F. De Meyer, Hendrik B. Feys, Peter J. Lenting, Seb Lamprecht, Jan Roodt, Walter J. Janse van Rensburg and Aline Vandenbulcke and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Inge Pareyn

41 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Pareyn Belgium 19 566 480 202 153 130 43 950
Gabriel M. Romo United States 12 605 1.1× 242 0.5× 91 0.5× 207 1.4× 41 0.3× 13 980
Keren Osman United States 11 352 0.6× 617 1.3× 107 0.5× 557 3.6× 68 0.5× 38 1.2k
O. C. Leeksma Netherlands 14 508 0.9× 252 0.5× 105 0.5× 142 0.9× 36 0.3× 25 826
JP Girma France 20 1.4k 2.4× 416 0.9× 261 1.3× 91 0.6× 82 0.6× 47 1.6k
Blanca Sánchez‐González Spain 20 598 1.1× 144 0.3× 196 1.0× 721 4.7× 28 0.2× 70 1.5k
Simon Le Gallou France 14 182 0.3× 551 1.1× 136 0.7× 158 1.0× 41 0.3× 23 896
Takehito Igarashi Japan 14 322 0.6× 371 0.8× 95 0.5× 153 1.0× 52 0.4× 38 871
A. Solanilla France 11 249 0.4× 164 0.3× 152 0.8× 164 1.1× 19 0.1× 20 662
Marion Ciudad France 15 368 0.7× 517 1.1× 159 0.8× 277 1.8× 19 0.1× 25 1.0k
Katherine Casper United States 10 270 0.5× 97 0.2× 84 0.4× 155 1.0× 25 0.2× 12 621

Countries citing papers authored by Inge Pareyn

Since Specialization
Citations

This map shows the geographic impact of Inge Pareyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Pareyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Pareyn more than expected).

Fields of papers citing papers by Inge Pareyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Pareyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Pareyn. The network helps show where Inge Pareyn may publish in the future.

Co-authorship network of co-authors of Inge Pareyn

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Pareyn. A scholar is included among the top collaborators of Inge Pareyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Pareyn. Inge Pareyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pareyn, Inge, Jasper Anckaert, Claudia Tersteeg, et al.. (2025). Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS. Blood Advances. 9(8). 1763–1771. 1 indexed citations
3.
Pareyn, Inge, et al.. (2024). Limited Impact of Drone Transport of Blood on Platelet Activation. Drones. 8(12). 752–752. 1 indexed citations
4.
Nix, Christoph, Antoine Rauch, An‐Sofie Schelpe, et al.. (2022). ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation. Journal of Thrombosis and Haemostasis. 20(12). 2797–2809. 9 indexed citations
5.
Schelpe, An‐Sofie, Elien Roose, Inge Pareyn, et al.. (2020). Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function. Blood Advances. 4(6). 1072–1080. 30 indexed citations
6.
Roose, Elien, Claudia Tersteeg, Bérangère S. Joly, et al.. (2020). Anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura do not hamper ELISA‐based quantification of ADAMTS13 antigen. Journal of Thrombosis and Haemostasis. 18(4). 985–990. 14 indexed citations
7.
Martinod, Kimberly, Linda Desender, Inge Pareyn, et al.. (2020). von Willebrand factor increases in experimental cerebral malaria but is not essential for late‐stage pathogenesis in mice. Journal of Thrombosis and Haemostasis. 18(9). 2377–2390. 4 indexed citations
8.
Schelpe, An‐Sofie, Christelle Orlando, Inge Pareyn, et al.. (2018). Child‐onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13. European Journal Of Haematology. 101(2). 191–199. 5 indexed citations
9.
Schelpe, An‐Sofie, Elien Roose, Bérangère S. Joly, et al.. (2018). Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients. Haematologica. 104(6). 1268–1276. 4 indexed citations
10.
Tersteeg, Claudia, Els Bailleul, Leen Delrue, et al.. (2018). Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome. Research and Practice in Thrombosis and Haemostasis. 2(4). 762–766. 6 indexed citations
11.
Denorme, Frederik, Peter Kraft, Inge Pareyn, et al.. (2017). Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease. PLoS ONE. 12(6). e0179258–e0179258. 25 indexed citations
12.
Vandeputte, Nele, Inge Pareyn, Zsuzsanna Izsvák, et al.. (2015). Long-term gene therapy for thrombotic thrombocytopenic purpura using the 'Sleeping Beauty' transposon system. Journal of Thrombosis and Haemostasis. 13. 154–154. 1 indexed citations
13.
Feys, Hendrik B., Jan Roodt, Nele Vandeputte, et al.. (2012). Inhibition of von Willebrand factor–platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons. Blood. 120(17). 3611–3614. 27 indexed citations
14.
Feys, Hendrik B., et al.. (2010). The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet‐decorated VWF strings in vivo. Journal of Thrombosis and Haemostasis. 8(10). 2305–2312. 28 indexed citations
15.
Meyer, Simon F. De, Inge Pareyn, Jan M. Baert, Hans Deckmyn, & Karen Vanhoorelbeke. (2006). False positive results in chimeraplasty for von Willebrand Disease. Thrombosis Research. 119(1). 93–104. 13 indexed citations
16.
Feys, Hendrik B., Fengzhen Liu, Ningzheng Dong, et al.. (2006). ADAMTS‐13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. Journal of Thrombosis and Haemostasis. 4(5). 955–962. 70 indexed citations
17.
Walle, Gerlinde R. Van de, Karen Vanhoorelbeke, Zsuzsa Májer, et al.. (2005). Two Functional Active Conformations of the Integrin α2β1, Depending on Activation Condition and Cell Type. Journal of Biological Chemistry. 280(44). 36873–36882. 35 indexed citations
18.
Ulrichts, Hans, M. Udvardy, Peter J. Lenting, et al.. (2005). Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V. Journal of Biological Chemistry. 281(8). 4699–4707. 101 indexed citations
19.
20.
Pareyn, Inge, Ágota Schlammadinger, Marc Hoylaerts, et al.. (2004). Plasma glycocalicin as a source of GPIbα in the von Willebrand factor ristocetin cofactor ELISA. Thrombosis and Haemostasis. 93(1). 165–171. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel M. Romo Breakdown of academic impact, for papers by Keren Osman Breakdown of academic impact, for papers by O. C. Leeksma Breakdown of academic impact, for papers by JP Girma Breakdown of academic impact, for papers by Blanca Sánchez‐González Breakdown of academic impact, for papers by Simon Le Gallou Breakdown of academic impact, for papers by Takehito Igarashi Breakdown of academic impact, for papers by A. Solanilla Breakdown of academic impact, for papers by Marion Ciudad Breakdown of academic impact, for papers by Katherine Casper
Rankless by CCL
2026